Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:16 PM ET 8-K
M&A Deal Bunker Hill Mining Corp. BHLL

Bunker Hill Mining M&A Deal with Silver47 Exploration Corp.

Bunker Hill Mining Corp. is providing a status update on its pending acquisition of Silver47 Exploration Corp. by filing historical and pro forma financial statements required for the transaction. The filing includes audited financials for Silver47 and Summa Silver Corp. to facilitate the incorporation of the deal into the company's registration statements.

Counterparty
Silver47 Exploration Corp.
4:16 PM ET 8-K
Equity Investment Alset Inc. AEI

Alset Equity Investment of $500K in DSS Inc.

Alset Inc. invested $500,000 in related party DSS Inc. by purchasing a convertible promissory note and warrants for 8,000,000 shares of DSS common stock. The note bears 3% interest and is convertible at $0.50 per share, while the warrants have an exercise price of $0.55 per share. Alset already holds a 39.4% equity interest in DSS, and both companies are under the common control of Chairman and CEO Chan Heng Fai.

Value
$500K
Counterparty
DSS Inc.
Term
5 years
4:16 PM ET 8-K
Capacity Expansion Quanome Technologies, Inc. QNME

Quanome Technologies Capacity Expansion: $18.8M Investment

Quanome Technologies entered into a purchase agreement with Compal Electronics to acquire 32 GPU server units for approximately $18.8 million. The company intends to deploy these servers to build out its artificial intelligence computing infrastructure business.

Value
$18.8M
Counterparty
Compal Electronics, Inc.
4:16 PM ET 8-K
Capital Raise Monroe Capital Income Plus Corp

Monroe Capital Income Plus Capital Raise

Monroe Capital Income Plus Corp reported an unregistered sale of equity securities under Item 3.02. As a Business Development Company (BDC), this typically represents the issuance of new shares to investors through a private placement or continuous offering.

4:16 PM ET 8-K
Leadership Change Nbt Bancorp Inc NBTB

Nbt Bancorp Leadership Change

NBT Bancorp Inc. increased its Board of Directors to thirteen members and appointed Kimberly A. Boynton as a new director, effective October 1, 2026. Ms. Boynton, a former CEO of Crouse Health with extensive experience in financial management and commercial real estate, will serve on the Audit, Compensation and Benefits, and Risk Management Committees.

Counterparty
Kimberly A. Boynton
4:15 PM ET 8-K
Loan & Debt Viking Acquisition Corp. II VII

Viking Acquisition Corp. II $544K Debt Financing with Viking Acquisition Sponsor II, LLC

Viking Acquisition Corp. II issued an amended and restated convertible unsecured promissory note to its sponsor for an aggregate principal amount of $544,080.00. The note, which includes a new $30,000 advance for working capital, is non-interest bearing and convertible into units at $10.00 per unit upon the consummation of a business combination.

Value
$544K
Counterparty
Viking Acquisition Sponsor II, LLC
Term
through initial business combination or winding up
4:15 PM ET 8-K
Leadership Change ProPetro Holding Corp. PUMP

ProPetro Holding Leadership Change

Celina Davila has resigned as Chief Accounting Officer and principal accounting officer of ProPetro Holding Corp., effective October 30, 2026. The company's current CFO, Caleb Weatherl, will serve as the interim principal accounting officer while a permanent replacement is sought.

4:15 PM ET 8-K
Loan & Debt K&F Growth Acquisition Corp. II KFII

K&F Growth Acquisition Corp. II $600K Debt Financing with Daniel Fetters and Edward King

K&F Growth Acquisition Corp. II issued two unsecured promissory notes totaling $600,000 to Daniel Fetters and Edward King for working capital purposes. The non-interest-bearing notes are payable upon the company's initial business combination or liquidation and include an option for the payees to convert the principal into units of the company.

Value
$600K
Counterparty
Daniel Fetters and Edward King
Term
through the earlier of business combination or liquidation
4:15 PM ET 8-K
M&A Deal TransDigm Group INC TDG

TransDigm Group Signs $240M M&A Deal with Extant Aerospace / Portfolio of commercial rotorcraft

TransDigm Group's operating unit, Extant Aerospace, has entered into a definitive agreement to acquire a portfolio of commercial rotorcraft, land systems, and business jet products, including a California facility, for approximately $240 million in cash. The acquisition is expected to close during fiscal year 2027, subject to regulatory approvals and customary closing conditions.

Value
$240M
Counterparty
Extant Aerospace (operating unit) / Portfolio of commercial rotorcraft, land systems, and business jet products
4:14 PM ET 8-K
Shareholder Meeting InPoint Commercial Real Estate Income, Inc. ICR-PA

InPoint Commercial Real Estate Income Shareholder Meeting

InPoint Commercial Real Estate Income, Inc. held its 2026 Annual Meeting of Stockholders on September 16, 2026. Stockholders elected five directors to the board and ratified the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

4:13 PM ET 8-K
Executive Compensation CVRx, Inc. CVRX

CVRx Executive Compensation

CVRx, Inc. appointed John Landry as Chief Financial Officer, effective October 12, 2026, succeeding Jared Oasheim. Mr. Landry's compensation package includes a $500,000 base salary, a 50% target cash incentive, and initial equity awards (75% options, 25% RSUs) representing 0.80% of total common shares outstanding.

Counterparty
John Landry
4:13 PM ET 8-K
Executive Compensation Blend Labs, Inc. BLND

Blend Labs Executive Compensation

Blend Labs, Inc. appointed Lina Rivas as Head of Accounting and principal accounting officer, effective September 21, 2026. Her compensation package includes a $300,000 base salary, a $75,000 target annual bonus, and 530,000 restricted stock units (RSUs) vesting over four years. Jason Ream will continue to serve as the company's principal financial officer.

Counterparty
Lina Rivas
4:13 PM ET 8-K
Leadership Change Toro Co TTC

Toro Leadership Change

The Toro Company has elected David W. Huml, the current President and CEO of Tennant Company, to its Board of Directors, effective immediately. The Board was expanded from ten to eleven members to accommodate the appointment, and Mr. Huml will serve on the Audit and Finance Committees with a term expiring at the 2027 annual meeting.

Counterparty
David W. Huml
4:11 PM ET 8-K
Shareholder Meeting Federal Home Loan Bank of Atlanta

Federal Home Loan Bank of Atlanta Shareholder Meeting

The Federal Home Loan Bank of Atlanta announced the results of its 2026 director elections, electing Kort Brown, Jim Edwards, David Sweiderk, and re-electing Kathleen C. McKinney to the Board. The directors will serve four-year terms beginning January 1, 2027, and ending December 31, 2030. The election was conducted by direct ballot in accordance with the Federal Home Loan Bank Act and FHFA regulations.

Term
4 years
4:11 PM ET 8-K
Capital Raise GT Biopharma, Inc. GTBP

GT Biopharma Capital Raise of $7.75M

GT Biopharma amended its securities purchase agreement to increase a private placement of Series M 10% Convertible Preferred Stock and warrants, raising the aggregate purchase price to $7.75 million. The deal includes 'Greenshoe Rights' allowing purchasers to potentially acquire additional preferred stock with an aggregate stated value of up to approximately $34.7 million. The company has committed to filing a registration statement for the resale of the underlying common stock within 30 days of closing.

Value
$7.75M
Counterparty
New Purchaser
4:11 PM ET 8-K
Leadership Change Travere Therapeutics, Inc. TVTX

Travere Therapeutics Leadership Change

Travere Therapeutics announced that Eric Dube, Ph.D., will step down as President, CEO, and Board member effective December 1, 2026. Bradley L. Campbell, former CEO of Amicus Therapeutics, has been appointed as his successor. Dr. Dube will remain as an Executive Advisor through February 15, 2027, to facilitate a smooth leadership transition.

Counterparty
Bradley L. Campbell
4:11 PM ET 8-K
Leadership Change Jack in the Box Inc JACK

Jack in the Box Leadership Change

Jack in the Box appointed former Starbucks CFO Rachel Ruggeri to its Board of Directors as an independent director and announced the retirement of director Michael Murphy. These changes were made in conjunction with an amendment to a cooperation agreement with GreenWood Investors, LLC, which extends standstill and voting provisions through the 2028 annual meeting window.

Counterparty
GreenWood Investors, LLC
4:11 PM ET Form 4
Insider Selling Dell Technologies Inc. DELL

Dell Technologies General Counsel & Secretary Richard J. Rothberg Sells $2.33M of Stock

Richard J. Rothberg, General Counsel & Secretary, sold 4,000 shares of Dell Technologies Inc. at $583.36 a share, worth $2.33M in total on Sep 17, 2026. Shares held after the trade: 132,415 (-2.9%).

Value
$2.33M
Shares
4,000
Price
$583.36
Role
General Counsel & Secretary
Holding change
-2.9%
Trade date
Sep 17, 2026
4:10 PM ET Form 4
Insider Selling Equitable Holdings, Inc. EQH

Equitable Holdings Insider Bertram L. Scott Sells $151K of Stock

Bertram L. Scott sold 2,780 shares of Equitable Holdings, Inc. at $54.35 a share, worth $151K in total on Sep 21, 2026. Shares held after the trade: 23,685 (-10.5%).

Value
$151K
Shares
2,780
Price
$54.35
Holding change
-10.5%
Trade date
Sep 21, 2026
4:10 PM ET 8-K
Capital Raise Bbcms Mortgage Trust 2026-M1

Bbcms Mortgage Trust 2026-M1 Capital Raise of $654M

BBCMS Mortgage Trust 2026-M1 entered into agreements to sell $548.3 million in public certificates and $105.4 million in private certificates. The transaction involves the issuance of commercial mortgage pass-through certificates backed by a pool of commercial and multifamily mortgage loans. The closing of the offering is scheduled for September 30, 2026.

Value
$654M
Counterparty
Barclays Capital Inc.
4:10 PM ET 8-K
Loan & Debt OppFi Inc. OPFI

OppFi $100M Debt Financing with UMB Bank, N.A.

OppFi Inc.'s subsidiary borrowed an initial $75 million under a new $100 million senior secured multi-draw term loan agreement with UMB Bank and other lenders. The facility carries a fixed interest rate of 12.50% (increasing to 13.50% after the company's pending acquisition of BNCCORP) and is secured by equity interests in special purpose vehicles holding consumer loan receivables. The remaining $25 million capacity is available to be drawn through February 2027.

Value
$100M
Counterparty
UMB Bank, N.A.
Term
4 years
4:10 PM ET 8-K
Loan & Debt Bunge Global SA BG

Bunge Global $8.8B Debt Financing

Bunge Global SA's subsidiaries extended the maturity dates for three revolving credit facilities totaling $8.8 billion in aggregate capacity. The extensions include a $1.1 billion 364-day facility extended to October 2027, a $4.2 billion 5-year facility extended to October 2031, and a $3.5 billion 3-year facility extended to October 2029.

Value
$8.8B
Term
1 year to 5 years
4:09 PM ET 8-K
Loan & Debt Sixth Street Lending Partners

Sixth Street Lending Partners $750M Debt Financing with U.S. Bank Trust Company, National Association

Sixth Street Lending Partners completed the issuance and sale of $750 million in 6.500% senior unsecured notes due 2031. The company intends to use the net proceeds to pay down outstanding indebtedness under its revolving credit and subscription facilities and for general corporate purposes.

Value
$750M
Counterparty
U.S. Bank Trust Company, National Association
Term
through Dec 2031
4:08 PM ET Form 4
Insider Selling Real Remax Group Inc. REAX

Real Remax Group Insider David L. Liniger Sells $1.01M of Stock

David L. Liniger sold 52,876 shares of Real Remax Group Inc. at $19.12 a share, worth $1.01M in total on Sep 17, 2026. Shares held after the trade: 5,539,905 (-0.9%).

Value
$1.01M
Shares
52,876
Price
$19.12
Holding change
-0.9%
Trade date
Sep 17, 2026
4:07 PM ET 8-K
Leadership Change Bridger Aerospace Group Holdings, Inc. BAER

Bridger Aerospace Group Holdings Leadership Change

Bridger Aerospace Group Holdings, Inc. appointed Rebecca Gerleman as Senior Vice President and Chief Accounting Officer, effective September 18, 2026. Ms. Gerleman previously served as the company's Senior Director of Technical Accounting & Financial Reporting and spent twelve years at Deloitte & Touche LLP prior to joining the firm.

4:07 PM ET 8-K
Leadership Change Turning Point Brands, Inc. TPB

Turning Point Brands Leadership Change

Graham Purdy has resigned as President, CEO, and board member of Turning Point Brands for personal reasons, effective September 30, 2026. The company's Board of Directors has appointed current Executive Chairman David E. Glazek to succeed him as CEO, effective October 1, 2026.

4:06 PM ET 8-K
Investor Presentation PDS Biotechnology Corp PDSB

PDS Biotechnology Investor Presentation

PDS Biotechnology Corporation filed an updated corporate presentation deck as an exhibit to its 8-K. The presentation provides an overview of the company's oncology drug development programs, including PDS0101 and PDS0301, as of September 2026. This filing serves as a strategic update for investors regarding the company's clinical trial pipeline and research collaborations.

4:06 PM ET 8-K
M&A Deal Lantheus Holdings, Inc. LNTH

Lantheus Holdings M&A Deal with Curium US Holdings LLC

Lantheus Holdings provided a regulatory update on its pending merger with Curium US Holdings LLC, noting that Curium voluntarily withdrew and refiled its HSR Act pre-merger notification to provide the FTC with additional time for review. The new 30-day waiting period is set to expire on October 21, 2026, and the parties still expect to close the transaction in the first half of 2027.

Counterparty
Curium US Holdings LLC
4:06 PM ET 8-K
M&A Deal Insight Molecular Diagnostics Inc. IMDX

Insight Molecular Diagnostics M&A Deal with Chronix Biomedical, Inc.

Insight Molecular Diagnostics (iMDx) entered into Amendment No. 2 to its merger agreement with Chronix, modifying the earnout structure related to the CNI Monitor technology. The amendment establishes that equity holders will receive a 10% royalty on sales until a potential sale of the technology occurs, at which point they will receive a final payment of 10% of the gross sale proceeds.

Counterparty
Chronix Biomedical, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.